# Vor Biopharma (VOR) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/VOR
## Company Profile
- Ticker: VOR
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Oncology
## Stock Data
- Close: 22.27 USD
- Market cap: 740179079.82 USD
- Last updated: 2026-08-05
## Business Overview
### Autoimmune B-Cell Therapy Company
Vor Bio is developing telitacicept for antibody-driven autoimmune diseases.
### Telitacicept
Telitacicept is a recombinant fusion protein that inhibits both BAFF and APRIL, reducing survival signals for autoreactive B cells and plasma cells.
### Global Phase 3 Programs
The UPSTREAM program is evaluating telitacicept in generalized myasthenia gravis and primary Sjögren’s disease.
## Why The Stock Is Moving

As of Aug 5, 2026, VOR was little changed and closed at $22.27. No new same-company headline was identified in the current news window.

## Future Catalysts

- Topline results from the Phase 3 UPSTREAM MG study are anticipated in the first half of 2027.

## Recent News
- 2026-07-07 20:01 EST — [Vor Bio Appoints David Zaccardelli to Board of Directors](https://biopharmsignal.com/news/VOR/vor-bio-appoints-david-zaccardelli-to-board-of-directors-7c744ed5) — Source: Vor Biopharma
- 2026-07-02 21:30 EST — [Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/VOR/vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ef99a3b3) — Source: Vor Biopharma
- 2026-06-08 12:31 EST — [Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China](https://biopharmsignal.com/news/VOR/telitacicept-receives-nmpa-approval-for-the-treatment-of-sj-gren-s-disease-in-ch-185b18e7) — Source: Vor Biopharma
- 2026-06-08 12:30 EST — [Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China](https://biopharmsignal.com/news/VOR/telitacicept-receives-nmpa-conditional-approval-for-the-treatment-of-iga-nephrop-59acfea5) — Source: Vor Biopharma
- 2026-05-28 12:30 EST — [Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/VOR/vor-bio-to-participate-in-the-2026-jefferies-global-healthcare-conference-045fc6d4) — Source: Vor Biopharma